MLLT10 and leukemia: Furthermore, deletion of the CRM1 C-terminal tail in a CRM1-AF10 fusion oncoprotein induced a more potent murine leukemia in mouse models when compared to a CRM1-AF10 fusion without the C-terminal tail deletion [4].